"The addition of Jnana's drug discovery technology and small molecule pipeline in PKU and autoimmune diseases will strengthen our R&D in the Boston area of the US, one of the most important ...

NGGT has initiated Phase I/II clinical trials in the U.S. and China to evaluate the safety and efficacy of NGGT002 for the <a ta ...

Q3 2024 Earnings Call Transcript November 7, 2024 PTC Therapeutics, Inc. beats earnings expectations. Reported EPS is $-1.39, ...

Other examples include obesity, Gaucher's disease, phenylketonuria (PKU), medium-chain acyl-CoA dehydrogenase deficiency (MCADD), maple ... Have to maintain bodyweight, no alcohol and avoid smoking.

Using drugs changes a person's brain structure and functioning, particularly in areas involved in reward, stress, and self-control. These alterations make it harder for people to stop using substances ...

The FDA issued its first stamp of approval for a cell or gene therapy back in 2017 to Novartis' Kymriah. | The gene therapy ...

DiveWire guarantees visibility for your news announcements through instant distribution to BioPharma Dive’s audience and its 153,500 newsletter subscribers for 21 days.

Symptoms can range from acute (short-term) mania to depression and depressive episodes. Luckily, multiple treatments exist that can help you manage the condition. Medications such as mood stabilizers, ...

Reported total revenue of $10.3 million and GAAP Net Income of $0.6 million, or $0.02 per diluted shareEntered into an asset purchase agreement ...

PKU GOLIKE continues to see strong interest since our acquisition earlier this year ... During the quarter, we received the exciting news that the FDA has accepted our new drug application for ET-400, ...

NEW YORK, Nov 12 (Reuters) - Pfizer (PFE.N), opens new tab is exploring the sale of its hospital drugs unit, as the drugmaker, which has been under pressure from activist investor Starboard Value ...